Contact this trialFirst, we need to learn more about you.
Enzyme Replacement Therapy
ELAPRASE + Prophylactic Therapy for Hunter Syndrome
Recruiting3 awardsPhase 4
Oakland, California
This trial investigates if a prophylactic therapy can prevent or reduce high titer antibodies in Hunter syndrome patients receiving ELAPRASE for up to 104 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.